Startups
BreezeBio
Edit

BreezeBio

https://breezebio.com/
Last activity: 25.04.2026
Active
Categories: BiotechGeneticMedicineImmunologyNanotechnologyOncologyTherapeutics
Built by leaders at the forefront of genetic medicine.
Mentions
2

Overview

Location
United States
Total raised
$60M

Investors 2

DateNameWebsite
Sign up to seeSign up to seeSign up to see
Apr 25, 2026Company K Partnerskpartners.co.kr

Funding Rounds 1

DateSeriesAmountInvestors
Sign up to seeSign up to seeSign up to seeSign up to see

Mentions in press and media 2

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Feb 26, 2026BreezeBio Closes Series B FundingBreezeBio, (fka as GenEdit), a San Francisco, CA-based biotechnology company developing genetic medicines, raised an undisclosed amount in Series B funding. The round was led by Yuanta Investment and DSC Investment, with participation from ...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about BreezeBio

How much funding has BreezeBio raised?

BreezeBio has raised $60M in total across 1 funding round.

Who has invested in BreezeBio?

Parsers VC lists 2 investors of BreezeBio, among them Company K Partners.

What has the press written about BreezeBio?

Parsers VC has collected 2 articles mentioning BreezeBio, among them “BreezeBio Closes Series B Funding” (Feb 26, 2026).

Is BreezeBio still active?

Yes, BreezeBio is active; its latest activity on Parsers VC dates from Apr 25, 2026.